Genomics and Public Health Action
Genomics and Population Health Action: Join the CollaborationPosted on by
- Identify opportunities for genomics to improve population health now and in the near future.
- Inform and communicate with population health policy makers and program officials.
- Integrate evidence-based applications into practice at the clinical/public health interface.
- The Evidence Working Group has identified a horizon scanning process to define genomics applications with enough evidence base at the population level.
- The Implementation Working Group is developing an online guide that will provide information for public health programs interested in integrating genomics into programs.
- Extending the scope of GPHAC to include health systems in addition to public health programs, as well as adding familial hypercholesterolemia (FH) to the list of priority conditions to explore. Just like hereditary cancer, FH is relatively common, affecting about 1 million people in the United States, and is severely underdiagnosed even though evidence-based recommendations exist to prevent heart disease morbidity and mortality.
- Forming two new working groups to increase the impact of GPHAC and develop tools for implementation and pilot projects that can be conducted in real world settings. The Cascade Screening Working Group is focused on developing tools and best practices for the identification and genetic testing of at-risk relatives of those individuals diagnosed with FH, LS, and HBOC. The Population Screening Working Group is designing an evidence-based framework that will provide the rationale and corresponding empirical data for the implementation of large-scale genomic sequencing programs in healthy adult populations.